Target intelligence / Profile preview

RAB GTPase activating protein 1 (RAB-GAP1)

Target
RAB-GAP1
Molecular classification
Enzyme, GTPase activating protein (GAP), TBC-domain protein, Regulatory protein
01

Overview

RAB GTPase activating protein 1 is a member of the TBC-domain (Tre-2, Bub2, Cdc16) family of GAPs that regulate Rab GTPases, key orchestrators of intracellular membrane trafficking. These proteins accelerate the intrinsic GTP hydrolysis on Rab GTPases, converting them from active (GTP-bound) to inactive (GDP-bound) states, thereby temporally and spatially terminating Rab signaling and ensuring proper membrane traffic and organelle identity[1][2][4]. Rab-GAPs, via their TBC domains, exhibit specificity for Rabs and are integral to maintaining the fidelity of cellular transport pathways; loss of function or mutation can lead to trafficking defects in model organisms[2]. These are not direct drug targets but are essential for the proper regulation of Rab-mediated transport mechanisms. If you require information on a particular human Rab-GAP (e.g., TBC1D1), clarification with an exact gene/protein name will yield more precise, structured information.

Other names
Rab-GAP1Gyp1 (in yeast)TBC-domain proteinRabGAPs (general family: TBC1D1, TBC1D2, etc.)
02

Mechanism of action

Not applicable; no drugs currently target Rab GAPs.

03

Biological functions

Regulation of Rab GTPase activityControl of membrane trafficOrganelle biogenesis and maturationEndocytic recyclingVesicle formation and transport
04

Disease associations

Disruption of GAP activity can contribute to trafficking defects and may be involved in diseases of membrane transport; members of the TBC-domain GAP family are being studied in metabolic disorders and neurodegeneration, but direct disease associations are limited.
05

Safety considerations

None specifically reported; challenges include cell viability upon functional loss due to trafficking defects
06

Interacting drugs

None known; these proteins are not direct drug targets.
07

Biomarkers

None known for clinical use.

Beyond the preview

Go deeper on RAB GTPase activating protein 1 (RAB-GAP1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RAB GTPase activating protein 1 (RAB-GAP1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call